NetScientific PLC NetScientific invests in Neumitra (4149M)
07 Maio 2015 - 3:01AM
UK Regulatory
TIDMNSCI
RNS Number : 4149M
NetScientific PLC
07 May 2015
NetScientific plc
("NetScientific" or the "Group")
NetScientific invests in wearable digital health company,
Neumitra
London, UK - 7 May 2015 - NetScientific (AIM: NSCI), the
biomedical and healthcare technology group, today announced its
investment in Neumitra, a digital health company, developing
wearable devices and smart software applications for the real-time
management of stress.
Neumitra develops embedded biomodules to accurately and
continuously measure how the autonomic nervous system is affected
by daily stresses, to establish the relationship between brain
health and performance. The company uses mobile software to link
contextual data, such as events, locations, and activities, with
the physiology of stress, sleep, and exercise. Their internet-based
analytics platform is designed to preserve participant anonymity
while uncovering health risk factors worldwide.
Research has long linked excessive stress to a host of physical
and mental health concerns, from heart disease, asthma, and
fertility to anxiety disorders and depression. Neumitra's mission
is to quantify brain health with a validated stress score for
real-time managing of symptoms, identifying their causes, and
aiding users and their doctors in managing follow-on health
concerns.
Neumitra's biomodules, already available as the neuma biowatch,
measure signals associated with the autonomic nervous system
including heart rate, skin conductance, temperature, and physical
activity to develop a library of personal and population
algorithms. The company is currently licensing its biomodules to
watch and jewellery manufacturers for widespread applications.
Neumitra is a portfolio company of Breakout Labs and it
represents the Group's fifth investment in a Breakout Labs
portfolio company since announcing its partnership with Peter
Thiel's revolving philanthropic fund in March 2014.
Michael Boyce-Jacino, PhD, US Executive Director at
NetScientific commented: "The wearable device market is seeing
rapid growth and has the potential to transform many areas of
healthcare by enabling real-time tracking and management of
symptoms by providing actionable feedback. Stress is an
often-overlooked cause of significant healthcare and productivity
costs in society which Neumitra is leading the way to better
understand and address. Our investment in Neumitra further broadens
our digital health portfolio, a key area of focus for the
Group."
Robert Goldberg, Ph.D., CEO of Neumitra added: "Whilst the
robust consumer interest in fitness trackers and smart watches is
exciting, we believe there isn't a product that goes far enough to
address health and performance concerns related to stress. At
Neumitra, we aim to aggregate large scale analytics and insights to
uncover how and when chronic stress adversely impacts the brain and
body.
"Our biomodules are giving us compelling data - with more
generated every day - that is helping deepen our understanding of
stress and what causes it throughout daily life demands. With a
biowatch already on the market, we are now focused on incorporating
our biomodules into smart devices, such as next-generation watches
and jewellery, for health and wellness. NetScientific's investment
will help drive our development of applications for brain health
concerns around the world."
- Ends -
About NetScientific
NetScientific is a biomedical and healthcare technology group
that funds and develops technologies that offer transformative
benefits to people's lives and society through improved diagnosis,
prognosis and treatment. For more information, please visit the
website at www.NetScientific.net
About Breakout Labs
Breakout Labs, a program of the Thiel Foundation, is reshaping
the way early-stage science and technology companies are funded.
Founded in 2011, Breakout Labs has supported 22 companies in areas
ranging from food science and biomedicine to clean energy. For many
of these companies, Breakout Labs was the first external investor.
Breakout Labs provides up to $350,000 for companies to achieve
specific milestones that are critical to their development. In
addition to funding, Breakout Labs companies benefit directly from
a 2-year program of mentorship and networking, with access to the
Thiel Foundation's large community of investors, innovators, and
entrepreneurs. Successful grantees return a capped royalty stream
and a small percentage of equity in their company to Breakout Labs
and thereby contribute to the next generation of scientific
innovation. For more information, see www.BreakoutLabs.org.
About Neumitra
Neumitra is a digital health company in Boston MA developing
embedded biomodules to accurately and continuously measure the
autonomic nervous system throughout daily life demands. The company
is a portfolio company of Peter Thiel's Breakout Labs. The founding
team met in 2009 in the Neurotechnology Ventures class at MIT and
united around the potential for helping people in their own lives
affected by brain health concerns. https://www.neumitra.com/
Contact Details
NetScientific Tel: +44 (0)77 2055
Peter Thoms, CFO 5752
Investec Tel: +44 (0)20 7597
Gary Clarence / Daniel 4000
Adams
Instinctif Partners Tel: +44 (0)20 7457
Melanie Toyne-Sewell / 2020 Email: netscientific@instinctif.com
Tim Watson
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCAFMFTMBIMBIA
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024